APMG Colon Molecular Pathways
Cancers | Free Full-Text | EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy
Frontiers | The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells
The Role of the Epidermal Growth Factor Receptor in the Mechanism and Treatment of Colorectal Cancer - Nirit Yarom - Discovery Medicine
Overview of the EGFR pathway and downstream signaling pathways,... | Download Scientific Diagram
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies | Journal of Experimental & Clinical Cancer Research | Full Text
JCI Insight - RasGRP1 is a potential biomarker for stratifying anti-EGFR therapy response in colorectal cancer
Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis - ScienceDirect
EGFR Signaling in Colorectal Carcinoma
Different EGFR signalling pathways induced by the interaction between... | Download Scientific Diagram
EGFR signaling in colorectal cancer: a clinical perspective | GICTT
Identification of a somatic EGFR mutation in colorectal adenocarcinoma... | Download Scientific Diagram
Y‑box‑binding protein 1 inhibits apoptosis and upregulates EGFR in colon cancer
Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives - Annals of Oncology
Anti-Epidermal Growth Factor Receptor (EGFR) Treatment in Patients with Metastatic Colorectal Cancer | IntechOpen
Diapositiva 1
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype | Science Translational Medicine
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR | Nature
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies | Journal of Experimental & Clinical Cancer Research | Full Text
Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancer | Pharmacogenomics
Comprehensive review of targeted therapy for colorectal cancer | Signal Transduction and Targeted Therapy
Frontiers | The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy
RESISTANCE TO ANTI-EGFR THERAPIES IN COLORECTAL CANCER – Sanguine Bio Researcher Blog
